Chief Scientific Officer of RowdMap, Inc. Joins

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Chief Scientific Officer of RowdMap, Inc. Joins AcademyHealth Health Datapalooza Steering Committee to Highlight How Government Data Drives Success in Value-Based Care

WASHINGTON, DC, Dec. 13, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Joshua Rosenthal, PhD, of RowdMap, Inc. joins the 2017 Health Datapalooza Steering Committee. Conceived as part of a public-private movement to liberate and use health data, the Datapalooza engages patient and consumer voices and brings national and international leaders from the C-levels of business and government together for discussions that improve health and health care and drive market value. AcademyHealth, a leading academic research institution that increases the understanding of methods and data used in the field, enhances the professional skills of researchers and research users, and expands awareness, is the organization that brings Health Datapalooza to the public every year.

Joshua Rosenthal, PhD, joins the AcademyHealth Health Datapalooza steering committee, which includes Niall Brennan, Chief Data Officer, Centers for Medicare & Medicaid Services (CMS); Amy Compton-Phillips, Chief Clinical Officer of Providence Health & Services; Greg Downing, Executive Director for Innovation, Department of Health and Human Services (HHS); Margo Edmunds, Vice President of Evidence Generation and Knowledge Translation at AcademyHealth; Liz Johnson, Chief Information Officer of Tenet Healthcare and David Carmouche, President of Ochsner Health Network, and others: http://bit.ly/2hqkUGI

The steering committee has organized several tracks including one dedicated to Payer and Provider Value-Based Care at the upcoming 2017 Datapalooza event. "Part of this year's event is getting the message out that public data is being used by health plans, hospitals and physician groups all across the country to successfully move from fee for service payment models to value-based care," said Joshua Rosenthal, PhD, Chief Scientific Officer, RowdMap, Inc.

One of the focuses will be how payers and providers can use data to create high-value care for patients. Identifying, quantifying, and reducing low-value care is a key to succeeding in new payment models. According to the Institute of Medicine (IOM), low-value care accounts for 30 cents of every dollar spent healthcare, accounting for over $850BB in 2014. Health Datapalooza has been instrumental at highlighting examples of health plans, hospitals and physician groups using newly released, publicly available data to improve quality in care. CMS has now released the largest data set in the history of the United States, covering virtually every provider, with years of longitude. More recently, CMS has released drug prescription and cost data. http://go.cms.gov/2gFFgL2 Health Datapalooza will highlight this sort of data being used by the delivery system to reduce costs, improve outcomes and patient experiences, and reduce the 30 cents of every dollar that goes to low-value care.

About RowdMap, Inc:

An Ernst and Young EY Entrepreneur Of The Year® winner, RowdMap's Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce no-value care that physicians deliver- a central tenet of successful pay-for-value programs.

Through practice patterns and referral analysis, RowdMap's benchmarks identify the health care entities that manage unwarranted and unexpected variation in care. This variation leads to more than $850 Billion in no-value care annually. Payers and physicians use RowdMap's physician and population health benchmarks to create strategies that put these highest performing physicians at the center of networks and then design products, organize clinical programs, and coordinate sales and marketing around them.

RowdMap's platform comes preloaded with benchmarks for every physician, hospital, and zip code in the United States- no IT integration required. RowdMap's Risk-Readiness® Platform works across all market segments and has significantly larger returns than traditional medical economics approaches.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2016/12/prweb13918933.htm

RowdMap, Inc. Joshua Rosenthal +1 8557693627

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Wells Fargo Adjusts American Tower's Position Amid Changes

Updated Category News Views 81

Wells Fargo's Recent Adjustments on American Tower Corporation In a recent move, Wells Fargo has made notable adjustments regarding American Tower Corporation (NYSE: AMT). The financial institution has downgraded the company’s stock from Overweight to Equal Weight while also reducing its price target to $230, down from $245. This decision stems from certain...

Continue Reading
WeightWatchers Completes Major Changes and Innovates Women's Health

Updated Category News Views 352

WeightWatchers Strengthens Leadership and Expands Health Initiatives WeightWatchers is making headlines as it completes a significant financial reorganization, enhancing its operational capabilities and leadership. With the appointment of respected figures in the health industry, including Dr. Kim Boyd as Chief Medical Officer, the Company aims to expand its services and...

Continue Reading
Understanding Short Interest Trends for FactSet Systems

Updated Category News Views 493

Unpacking the Short Interest for FactSet Research Systems FactSet Research Systems's short percent of float has seen a decline of 7.56% since its last report, reflecting a changing sentiment among traders. The recent data indicates that the company currently has 2.16 million shares sold short, equating to 6.48% of all its regular shares available for trading. Looking at...

Continue Reading
Investor Insights: Bausch + Lomb Faces Scrutiny Over Stock Drop

Updated Category News Views 177

Investor Insights: Bausch + Lomb Faces Scrutiny Over Stock Drop Bausch + Lomb Corporation, known for its high-quality vision and eye health products, has recently come under fire as Pomerantz LLP initiates a probe on behalf of its investors. This legal investigation stems from potential securities fraud or other irregularities that may affect the company’s integrity and...

Continue Reading
EquipmentShare IPO Lawsuit: Implications for EQPT Investors

Updated Category News Views 7

EquipmentShare Faces Legal Storm Alright folks, plenty of us have been around the block long enough to know that when a new IPO gets hitched up to a lawsuit train, you better sit up and take notice. EquipmentShare.com, Inc. (NASDAQ:EQPT), a name that not too long ago was supposed to be a hotshot player in the cloud-based equipment rental game, is knee-deep in legal muck...

Continue Reading